Syros Pharmaceuticals, Inc.
Q3 2023 13F Holders
Symbol
SYRS
CUSIP
87184Q206
Type
Equity
Class
COM NEW
Num filers
50
Total reported value, excl. options
$47.9M
Compare 2023 Q3 to
2025 Q1
2024 Q4
2024 Q3
2024 Q2
2024 Q1
2023 Q4
2023 Q2
2023 Q1
2022 Q4
2022 Q3
Excl. options
Options only
All
Manager
Report Date
Value ($000)
Shares